Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection.
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection.
复制标题
氟西汀用于SARS-CoV-2感染的抗炎治疗。
DOI:
10.1016/j.biopha.2021.111437
复制
发表时间:
2021-06
期刊:
影响因子:
--
通讯作者:
McCullumsmith CB
中科院分区:
文献类型:
--
作者:
Creeden JF;Imami AS;Eby HM;Gillman C;Becker KN;Reigle J;Andari E;Pan ZK;O'Donovan SM;McCullumsmith RE;McCullumsmith CB
Hyperinflammatory response caused by infections such as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases organ failure, intensive care unit admission, and mortality. Cytokine storm in patients with Coronavirus Disease 2019 (COVID-19) drives this pattern of poor clinical outcomes and is dependent upon the activity of the transcription factor complex nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) and its downstream target gene interleukin 6 (IL6) which interacts with IL6 receptor (IL6R) and the IL6 signal transduction protein (IL6ST or gp130) to regulate intracellular inflammatory pathways. In this study, we compare transcriptomic signatures from a variety of drug-treated or genetically suppressed (i.e. knockdown) cell lines in order to identify a mechanism by which antidepressants such as fluoxetine demonstrate non-serotonergic, anti-inflammatory effects. Our results demonstrate a critical role for IL6ST and NF-kappaB Subunit 1 (NFKB1) in fluoxetine’s ability to act as a potential therapy for hyperinflammatory states such as asthma, sepsis, and COVID-19.
登录
查看更多内容
影响因子:
39.3
作者:
Liu T;Zhang L;Joo D;Sun SC
通讯作者:
Sun SC
影响因子:
5.6
作者:
Durairaj H;Steury MD;Parameswaran N
通讯作者:
Parameswaran N
影响因子:
1.8
作者:
Newton, Michael A.;Quintana, Fernando A.;Ahlquist, Paui
通讯作者:
Ahlquist, Paui
影响因子:
5.8
作者:
Roumestan C;Michel A;Bichon F;Portet K;Detoc M;Henriquet C;Jaffuel D;Mathieu M
通讯作者:
Mathieu M
影响因子:
5.6
作者:
Hu, Hui-Min;Li, Bin;Hao, Ding-Jun
通讯作者:
Hao, Ding-Jun